XASX
COH
Market cap6.34bUSD
Sep 17, Last price
136.39AUD
1D
-0.62%
1Q
15.45%
Jan 2017
11.29%
Name
Cochlear Ltd
Chart & performance
P/E
60.56
P/S
3.82
EPS
2.25
Div yield, %
4.73%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
9.35%
Revenues
2.33b
-0.36%
Net income
147m
-62.12%
CFO
368m
+54.88%
Dividend
Sep 21, 20261.3 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world. The company's diverse product range features cochlear implant systems, enhanced sound processor upgrades, bone conduction technology, and a variety of complementary accessories and related items. Founded in 1981, Cochlear Limited is headquartered in Sydney, Australia.
Related entities
Subsidiaries
COCHLEAR MEDICAL DEVICE COMPANY INDIA PRIVATE LIMITED
Key people
Non-Executive Independent Chairman of the Board · since 2010
Diggory William Howitt
President, Chief Executive Officer, Executive Director · since 2018
Brent Cubis
Chief Financial Officer · since 2017
Anthony Bishop
President - Asia Pacific Region · since 2016
Richard Brook
President - EMEA & Latin American Region · since 2017
Tony Manna
President - Americas Region
Rom Mendel
President, Acoustics
Stuart Sayers
President - Services · since 2016
Greg Bodkin
Senior Vice President - Supply Chain & Operational Excellence · since 2018
Jennifer Hornery
Senior Vice President - People & Culture · since 2017
Jan Janssen
Chief Technology Officer · since 2017
David Hackshall
Chief Information Officer · since 2015
Dean Phizacklea
Senior Vice President - Global Marketing · since 2016
Ray Jarman
Company Secretary · since 2017
Director · since 2020
Non-Executive Director · since 2005
Non-Executive Independent Director · since 2015
Non-Executive Independent Director · since 2015
Shah Abbas Hussain
Non-Executive Independent Director · since 2018
Bruce Gregory Robinson
Independent Non-Executive Director · since 2016
IPO date
Dec 04, 1995
Employees
4,800
Domiciled in
AU
Incorporated in
AU
Headquarters & legal address
1 University Avenue
Macquarie University 2109
AU
Macquarie University 2109
AU
Previous name
Cochlear Pty Ltd
Previous name
Nexus Biomedical Pty Ltd
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||